We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

Back to rankings

79 hedge funds and large institutions have $68.9M invested in Immunomedics Inc in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 24

8% less call options, than puts

Call options by funds: $2.72M | Put options by funds: $2.96M

7% less funds holding

Funds holding: 85 → 79 (-6)

28% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 18

58% less capital invested

Capital invested by funds: $166M → $68.9M (-$97.1M)

Holders
79
Holders Change
-6
Holders Change %
-7.06%
% of All Funds
2.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
27
Reduced
24
Closed
18
Calls
$2.72M
Puts
$2.96M
Net Calls
-$241K
Net Calls Change
-$2.48M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$8.48M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$5.12M
3
ACP
Acuta Capital Partners
California
+$4.37M
4
Goldman Sachs
Goldman Sachs
New York
+$713K
5
PAM
Panagora Asset Management
Massachusetts
+$535K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$10.2M
2
WCM Investment Management
WCM Investment Management
California
-$8.09M
3
State of Wisconsin Investment Board
State of Wisconsin Investment Board
Wisconsin
-$6.09M
4
PA
Perceptive Advisors
New York
-$2.44M
5
CS
Candriam SCA
Luxembourg
-$1.34M
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
51
Commonwealth Equity Services
Massachusetts
$52K -$2.04K -800 -3%
Citadel Advisors
52
Citadel Advisors
Florida
$48K +$72K +28,195 New
OC
53
Oppenheimer & Co
New York
$46K -$169K -66,056 -71%
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$46K -$58.6K -22,975 -46%
HW
55
Hancock Whitney
Mississippi
$45K – – –
VKH
56
Virtu KCG Holdings
New York
$40K +$8.38K +3,282 +16%
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$38.7K +$37K +14,499 +181%
Group One Trading
58
Group One Trading
Illinois
$34K +$50.9K +19,958 New
Barclays
59
Barclays
United Kingdom
$30K -$307K -120,459 -81%
Principal Financial Group
60
Principal Financial Group
Iowa
$29K -$24.2K -9,465 -36%
Stifel Financial
61
Stifel Financial
Missouri
$29K +$43.4K +17,000 New
Legal & General Group
62
Legal & General Group
United Kingdom
$27K – – –
ID
63
Integral Derivatives
New York
$25K +$36.5K +14,282 New
NFG
64
Next Financial Group
Texas
$22K +$10.2K +4,000 +44%
PPA
65
Parametric Portfolio Associates
Washington
$20K +$30K +11,735 New
Citigroup
66
Citigroup
New York
$19K -$32.1K -12,565 -53%
UBS Group
67
UBS Group
Switzerland
$19K -$27.2K -10,640 -49%
Teacher Retirement System of Texas
68
Teacher Retirement System of Texas
Texas
$19K +$19K +7,433 +215%
Millennium Management
69
Millennium Management
New York
$17K -$851K -333,547 -97%
AB
70
Amalgamated Bank
New York
$17K +$25.9K +10,150 New
BG
71
BlackRock Group
United Kingdom
$15K +$22.9K +8,968 New
Bank of America
72
Bank of America
North Carolina
$7K -$30K -11,738 -74%
SSB
73
Sandy Spring Bank
Maryland
$7K – – –
BlackRock
74
BlackRock
New York
$3K – – –
KCM
75
Karp Capital Management
California
$3K – – –
1 2
3
4

IMMU Hedge Fund Activity: Q3 2015 in Review

79 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2015, worth a combined $68.9M — down 58% from $166M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of IMMU and 13 opened new positions — a net loss of 5 holders — while 24 trimmed existing stakes and 27 added.

The largest buyer was OrbiMed, opening a new position worth an estimated $8.48M. The largest seller was Deerfield Management, exiting entirely with an estimated $10.2M sold.

  • 79 institutional investors held Immunomedics Inc (IMMU) as of Q3 2015, down from 85 in Q2 2015.
  • Funds reported $68.9M of Immunomedics Inc stock for Q3 2015, down 58% quarter-over-quarter.
  • 13 funds opened new Immunomedics Inc positions in Q3 2015 and 18 closed out, a net change of -5 holders.
  • The largest Immunomedics Inc buyer in Q3 2015 was OrbiMed, an estimated $8.48M added.
  • The largest Immunomedics Inc seller in Q3 2015 was Deerfield Management, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2015.